肺部的神经内分泌瘤:最新的更新
1Department of Thoracic Surgery, University of Milan, Milan 20122, Italy. riccardo.orlandi@unimi.it.
World journal of clinical oncology
|June 12, 2025
概括
本综述涵盖了肺部神经内分泌瘤,包括典型和非典型瘤和癌瘤,基于2021年世界卫生组织的分类. 它详细介绍了它们的流行病学,诊断,治疗和预后,强调了最近的进展和未来的方向.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 肺部病理学 肺部病理学
背景情况:
- 神经内分泌瘤 (NENs) 起源于神经内分泌细胞,通常影响胃肠道和肺部.
- 2021年世界卫生组织 (WHO) 的分类将肺NEN作为一个独特的类别,包括典型和非典型的癌,小细胞和大细胞神经内分泌癌.
研究的目的:
- 提供肺部神经内分泌瘤的全面概述.
- 讨论这些瘤的流行病学,临床,诊断,治疗和预后方面.
- 突出2021年世卫组织分类的最新更新,并探索未来的前景.
主要方法:
- 对流行病学,临床,诊断和治疗数据的文献综述.
- 对2021年世界卫生组织 (WHO) 肺癌分类的分析.
- 对肺部神经内分泌瘤当前挑战和未来研究方向的综合分析.
主要成果:
- 肺部神经内分泌瘤被分为典型的癌症,非典型的癌症,小细胞神经内分泌癌和大细胞神经内分泌癌.
- 2021年世卫组织分类为这些瘤的命名和分类提供了最新的见解.
- 在了解肺部NEN的流行病学,诊断和治疗方面取得了重大进展.
结论:
- 肺部神经内分泌瘤代表了一组异质的瘤,具有不同的亚型.
- 2021年世卫组织分类为了解和管理这些瘤提供了一个精细的框架.
- 持续的研究对于应对当前的挑战和改善肺NEN患者的治疗结果至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K


